Veracyte, Inc.(VCYT)NASDAQ
Stock Performance & Returns
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
VCYT | 3.59 B | 31.91x | 15.50% | 20.37% | $1.40 | 8.77% | 2.89 | - | $60.91 | $29.38 |
TMO | 228.66 B | 33.25x | 10.50% | 15.04% | $18.60 | 13.52% | 0.81 | 30.00% | $647.00 | $434.83 |
DHR | 148.35 B | 37.55x | 5.50% | 15.95% | $5.62 | 7.61% | 0.53 | 74.00% | $241.78 | $160.60 |
NTRA | 47.23 B | -244.53x | 37.70% | -7.11% | $-1.34 | -12.54% | 0.13 | - | $343.18 | $157.43 |
ILMN | 33.47 B | 41.67x | 9.40% | 18.34% | $5.32 | 32.34% | 0.89 | - | $231.81 | $88.00 |
GH | 21.61 B | -46.68x | 44.30% | -38.33% | $-3.45 | - | - | - | $176.58 | $53.40 |
Peer Valuation & Performance Analysis
Peer group analysis for Veracyte, Inc. (VCYT) compared to its primary competitors (including TMO, DHR, NTRA) reveals distinct metrics. VCYT trades at a valuation premium compared to its competitors, with a P/E ratio of 31.9x versus the peer average of -35.7x (representing a -189% premium). This indicates that the market expects superior growth or commands a quality premium for VCYT. In terms of growth, VCYT's revenue growth of 15.5% lags behind the peer average of 21.5%, indicating potential market share losses or slower industry adoption. Additionally, it boasts superior profitability with a net margin of 20.4% compared to the peer average of 0.8%, demonstrating strong cost controls and pricing power.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• VCYT ranks #1 in P/E ratio, #2 in revenue growth, and #1 in profit margins
• Average ranking: #1 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-09-03 | $45.36 | $45.99 | $44.12 | $44.67 | 673,700 | -1.52% |
| 2026-09-02 | $43.51 | $45.65 | $43.48 | $44.88 | 1,371,700 | +3.15% |
| 2026-09-01 | $42.97 | $43.74 | $42.28 | $43.43 | 873,000 | +1.07% |
| 2026-08-31 | $42.33 | $43.34 | $41.60 | $43.19 | 1,472,100 | +2.03% |
| 2026-08-28 | $45.20 | $45.55 | $43.32 | $43.34 | 1,684,100 | -4.13% |
| 2026-08-27 | $44.20 | $45.50 | $44.19 | $45.25 | 1,328,200 | +2.38% |
| 2026-08-26 | $43.78 | $44.52 | $43.25 | $44.29 | 2,181,500 | +1.16% |
| 2026-08-25 | $42.01 | $44.10 | $41.80 | $44.04 | 1,154,900 | +4.83% |
| 2026-08-24 | $42.00 | $42.07 | $41.02 | $41.47 | 1,165,400 | -1.26% |
| 2026-08-21 | $42.18 | $42.54 | $41.10 | $42.31 | 1,005,500 | +0.31% |
| 2026-08-20 | $41.67 | $42.45 | $41.05 | $41.79 | 980,400 | +0.29% |
| 2026-08-19 | $41.92 | $42.52 | $40.09 | $42.19 | 1,761,600 | +0.64% |
| 2026-08-18 | $41.80 | $42.35 | $40.35 | $40.68 | 1,143,200 | -2.68% |
| 2026-08-17 | $40.96 | $42.50 | $40.96 | $42.08 | 1,574,000 | +2.73% |
| 2026-08-14 | $42.54 | $43.13 | $41.00 | $41.25 | 1,668,000 | -3.03% |
Explore More Analysis for VCYT
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.